Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ for Suppression of Inflammatory Responses.

Luo L, Wall AA, Tong SJ, Hung Y, Xiao Z, Tarique AA, Sly PD, Fantino E, Marzolo MP, Stow JL.

Cell Rep. 2018 Sep 11;24(11):3033-3044. doi: 10.1016/j.celrep.2018.08.028.

2.

Differential expression of genes and receptors in monocytes from patients with cystic fibrosis.

Tarique AA, Sly PD, Cardenas DG, Luo L, Stow JL, Bell SC, Wainwright CE, Fantino E.

J Cyst Fibros. 2019 May;18(3):342-348. doi: 10.1016/j.jcf.2018.07.012. Epub 2018 Sep 1.

PMID:
30177416
3.

CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.

Tarique AA, Sly PD, Holt PG, Bosco A, Ware RS, Logan J, Bell SC, Wainwright CE, Fantino E.

J Cyst Fibros. 2017 Jul;16(4):475-482. doi: 10.1016/j.jcf.2017.03.011. Epub 2017 Apr 17.

4.

Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages.

Tarique AA, Logan J, Thomas E, Holt PG, Sly PD, Fantino E.

Am J Respir Cell Mol Biol. 2015 Nov;53(5):676-88. doi: 10.1165/rcmb.2015-0012OC.

5.

Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.

Tarique AA, Kalsy A, Arifuzzaman M, Rollins SM, Charles RC, Leung DT, Harris JB, Larocque RC, Sheikh A, Bhuiyan MS, Saksena R, Clements JD, Calderwood SB, Qadri F, Kovác P, Ryan ET.

Clin Vaccine Immunol. 2012 Apr;19(4):594-602. doi: 10.1128/CVI.05689-11. Epub 2012 Feb 22.

6.

Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission.

Bishop AL, Tarique AA, Patimalla B, Calderwood SB, Qadri F, Camilli A.

J Infect Dis. 2012 Feb 1;205(3):412-21. doi: 10.1093/infdis/jir756. Epub 2011 Dec 5.

7.

Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age.

Matsuda F, Chowdhury MI, Saha A, Asahara T, Nomoto K, Tarique AA, Ahmed T, Nishibuchi M, Cravioto A, Qadri F.

Vaccine. 2011 Feb 24;29(10):1855-8. doi: 10.1016/j.vaccine.2010.12.133. Epub 2011 Jan 12. Erratum in: Vaccine. 2011 Aug 11;29(35):6068.

PMID:
21236234
8.

Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh.

Kendall EA, Tarique AA, Hossain A, Alam MM, Arifuzzaman M, Akhtar N, Chowdhury F, Khan AI, Larocque RC, Harris JB, Ryan ET, Qadri F, Calderwood SB.

Infect Immun. 2010 Jan;78(1):253-9. doi: 10.1128/IAI.00868-09. Epub 2009 Oct 26.

9.

Memory T-cell responses to Vibrio cholerae O1 infection.

Weil AA, Arifuzzaman M, Bhuiyan TR, LaRocque RC, Harris AM, Kendall EA, Hossain A, Tarique AA, Sheikh A, Chowdhury F, Khan AI, Murshed F, Parker KC, Banerjee KK, Ryan ET, Harris JB, Qadri F, Calderwood SB.

Infect Immun. 2009 Nov;77(11):5090-6. doi: 10.1128/IAI.00793-09. Epub 2009 Aug 24.

Supplemental Content

Loading ...
Support Center